134 related articles for article (PubMed ID: 37033563)
61. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
62. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
63. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
64. The Influence of Social Determinants on Late Stage Breast Cancer for Women in Mississippi.
Fortune ML
J Racial Ethn Health Disparities; 2017 Feb; 4(1):104-111. PubMed ID: 26902946
[TBL] [Abstract][Full Text] [Related]
65. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types.
Zhu F; Wang H; Ashamalla H
Pancreas; 2020; 49(10):1355-1363. PubMed ID: 33122525
[TBL] [Abstract][Full Text] [Related]
66. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer.
Eskander MF; Gil L; Beal EW; Li Y; Hamad A; Oppong B; Obeng-Gyasi S; Tsung A
Ann Surg Oncol; 2022 Feb; 29(2):1271-1277. PubMed ID: 34655352
[TBL] [Abstract][Full Text] [Related]
67. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
68. Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States.
Howard JM; Nandy K; Woldu SL; Margulis V
JAMA Netw Open; 2021 Jun; 4(6):e2112813. PubMed ID: 34106265
[TBL] [Abstract][Full Text] [Related]
69. Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database.
Sharma P; Ashouri K; Zargar-Shoshtari K; Luchey AM; Spiess PE
Urol Oncol; 2016 Mar; 34(3):122.e9-15. PubMed ID: 26547834
[TBL] [Abstract][Full Text] [Related]
70. Does Community Affluence Improve Survival of Colorectal Cancer?
Nemesure B; Mermelstein LK; Scarbrough KH
AJPM Focus; 2023 Dec; 2(4):100144. PubMed ID: 37941822
[TBL] [Abstract][Full Text] [Related]
71. Healthcare disparities in outcomes of patients with resectable pancreatic cancer.
Moaven O; Richman JS; Reddy S; Wang T; Heslin MJ; Contreras CM
Am J Surg; 2019 Apr; 217(4):725-731. PubMed ID: 30583797
[TBL] [Abstract][Full Text] [Related]
72. Clinical and demographic predictors of late-stage cervical cancer.
Ferrante JM; Gonzalez EC; Roetzheim RG; Pal N; Woodard L
Arch Fam Med; 2000 May; 9(5):439-45. PubMed ID: 10810949
[TBL] [Abstract][Full Text] [Related]
73. Associations Between Social Risk Factors and Surgical Site Infections After Colectomy and Abdominal Hysterectomy.
Qi AC; Peacock K; Luke AA; Barker A; Olsen MA; Joynt Maddox KE
JAMA Netw Open; 2019 Oct; 2(10):e1912339. PubMed ID: 31577353
[TBL] [Abstract][Full Text] [Related]
74. Influence of Socioeconomic Status on Stage at Presentation of Laryngeal Cancer in the United States.
Lebo NL; Khalil D; Balram A; Holland M; Corsten M; Ted McDonald J; Johnson-Obaseki S
Otolaryngol Head Neck Surg; 2019 Nov; 161(5):800-806. PubMed ID: 31184265
[TBL] [Abstract][Full Text] [Related]
75. Influence of Race, Income, Insurance, and Education on the Rate of Breast Reconstruction.
Restrepo DJ; Boczar D; Huayllani MT; Sisti A; Gabriel E; McLaughlin SA; Bagaria S; Spaulding AC; Rinker BD; Forte AJ
Anticancer Res; 2019 Jun; 39(6):2969-2973. PubMed ID: 31177137
[TBL] [Abstract][Full Text] [Related]
76. The Effect of Payer Status on Survival of Patients With Prostate Cancer.
Suh W; Master S; Liu L; Mills G; Shi R
Cureus; 2021 Feb; 13(2):e13329. PubMed ID: 33738172
[TBL] [Abstract][Full Text] [Related]
77. The association of health insurance with the survival of cancer patients with brain metastases at diagnosis.
Kolomaya A; Amin S; Lin C
Tech Innov Patient Support Radiat Oncol; 2021 Dec; 20():46-53. PubMed ID: 34926840
[TBL] [Abstract][Full Text] [Related]
78. Mitigating disparities in breast cancer treatment at an academic safety-net hospital.
Beaulieu-Jones BR; Shewmaker G; Fefferman A; Kenzik K; Zhang T; Drake FT; Sachs TE; Hirsch AE; Merrill A; Ko NY; Cassidy MR
Breast Cancer Res Treat; 2023 Apr; 198(3):597-606. PubMed ID: 36826701
[TBL] [Abstract][Full Text] [Related]
79. Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era.
Lamba N; Ott PA; Iorgulescu JB
JAMA Netw Open; 2022 Aug; 5(8):e2225459. PubMed ID: 36006646
[TBL] [Abstract][Full Text] [Related]
80. Is Insurance Status Associated with the Likelihood of Operative Treatment of Clavicle Fractures?
Congiusta DV; Amer KM; Merchant AM; Vosbikian MM; Ahmed IH
Clin Orthop Relat Res; 2019 Dec; 477(12):2620-2628. PubMed ID: 31764322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
